Guidance for Lam Research (LRCX)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
Q3 2024 | $6.15 – $7.65 | $6.64 | $3.40B – 4.00B | $3.68B | = Maintained | Details |
Q2 2024 | $6.25 – $7.75 | $6.79 | $3.40B – 4.00B | $3.65B | = Maintained | Details |
Q1 2024 | $6.05 | $5.60 | $3.40B | $3.30B | Raised | Details |
Q4 2023 | $4.25 – $5.75 | $5.63 | $2.80B – 3.40B | $3.47B | Lowered | Details |
Q2 2023 | $9.25 – $10.75 | $9.47 | $4.80B – 5.10B | $4.91B | = Maintained | Details |
Q1 2023 | $7.45 | $8.72 | $4.25B | $4.49B | Lowered | Details |
Q3 2022 | $7.87 – $8.87 | $8.47 | $4.15B – 4.65B | $4.40B | = Maintained | Details |
Q3 2022 | $7.75 – $10.25 | $8.82 | $4.60B – 5.20B | $4.63B | = Maintained | Details |
Q3 2022 | $6.50 – $8.00 | $8.24 | $3.90B – 4.50B | $4.46B | = Maintained | Details |
Q1 2022 | $7.60 – $8.60 | $7.77 | $4.05B – 4.55B | $4.07B | = Maintained | Details |
Q4 2021 | $7.00 – $8.00 | $6.74 | $3.75B – 4.25B | $3.68B | Raised | Details |
Q3 2021 | $6.15 – $6.95 | $5.72 | $3.50B – 3.90B | $3.31B | = Maintained | Details |
Q2 2021 | $5.20 – $6.00 | $5.16 | $3.10B – 3.50B | $3.08B | Raised | Details |
Q1 2021 | $4.75 – $5.55 | $4.14 | $2.90B – 3.30B | $2.72B | Raised | Details |
Q3 2020 | $4.55 | $4.00 | $2.80B | $2.58B | Raised | Details |
Q2 2020 | $3.80 | $3.15 | $2.50B | $2.18B | Raised | Details |
Q1 2020 | $2.71 – $3.11 | $3.23 | $2.00B – 2.30B | $2.29B | = Maintained | Details |
2019 | $3.20 – $3.60 | $3.33 | $2.20B – 2.50B | $2.34B | = Maintained | Details |
Q3 2019 | $3.01 – $3.41 | $3.36 | $2.25B – 2.55B | $2.45B | = Maintained | Details |
Q2 2019 | $3.65 | $3.35 | $2.50B | $2.38B | = Maintained | Details |
Q1 2019 | $3.20 | $3.88 | $2.30B | $2.76B | = Maintained | Details |
Q4 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2018 | $3.13 – $3.37 | $2.76 | $2.25B – 2.45B | $2.18B | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2017 | $2.55 | $2.46 | $2.13B | $2.02B | = Maintained | Details |
Q2 2017 | $2.08 – $2.28 | $1.62 | $1.77B – 1.92B | $1.65B | = Maintained | Details |
Q1 2017 | $1.67 – $1.87 | N/A | N/A | N/A | = Maintained | Details |
Q4 2016 | $1.53 – $1.73 | $1.54 | $1.53B – 1.58B | $1.49B | Raised | Details |
Q3 2016 | $1.07 | $1.31 | N/A | N/A | Lowered | Details |
Q2 2016 | $1.32 – $1.52 | $1.30 | $1.34B – 1.49B | $1.40B | = Maintained | Details |
Q4 2015 | $1.39 – $1.54 | $1.35 | $1.55B – 1.65B | $1.39B | = Maintained | Details |
Q3 2015 | $1.23 – $1.37 | $1.30 | $1.32B – 1.42B | $1.34B | = Maintained | Details |
Q1 2015 | $1.70 | $1.38 | $1.60B | $1.41B | Raised | Details |
Q3 2014 | $1.10 – $1.20 | $1.11 | $1.19B – 1.25B | $1.15B | = Maintained | Details |
Q1 2014 | $0.85 – $0.99 | $1.00 | N/A | N/A | Lowered | Details |
Q4 2013 | $0.97 – $1.07 | $0.95 | $0.98B – 1.13B | $1.10B | = Maintained | Details |